São Paulo - Delayed Quote BRL
Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
8.72
+0.01
+(0.11%)
As of 11:33:16 AM GMT-3. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 1.03 | 1.35 |
| Low Estimate | 0 | 0 | 1.03 | 1.35 |
| High Estimate | 0 | 0 | 1.03 | 1.35 |
| Year Ago EPS | -- | -- | 0.79 | 1.03 |
Revenue Estimate
| Currency in BRL | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 4 | 4 |
| Avg. Estimate | 1.36B | -- | 5.53B | 6.2B |
| Low Estimate | 1.35B | -- | 5.38B | 6.1B |
| High Estimate | 1.36B | -- | 5.75B | 6.31B |
| Year Ago Sales | 1.32B | -- | 4.94B | 5.53B |
| Sales Growth (year/est) | 2.50% | -- | 11.85% | 12.15% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.03 | 1.35 |
| 7 Days Ago | 0 | 0 | 1.03 | 1.35 |
| 30 Days Ago | 0 | 0 | 1.03 | 1.35 |
| 60 Days Ago | 0 | 0 | 1.03 | 1.35 |
| 90 Days Ago | 0 | 0 | 1.16 | 1.42 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PNVL3.SA | -- | -- | 30.88% | 31.07% |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Related Tickers
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
AMGN.MX Amgen Inc.
5,500.00
0.00%
4AB.F AbbVie Inc.
155.80
+0.65%
OPHLY Ono Pharmaceutical Co., Ltd.
4.1500
+5.87%
PFIZ34.SA Pfizer Inc.
32.20
+1.26%
ORNBVh.XC
NOV.MU Novo Nordisk A/S
54.64
+0.37%
GRF-P.MC Grifols SA
6.37
-0.55%
0R34.IL Johnson & Johnson
153.95
-2.50%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%